The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance

Clinica Chimica Acta

Volumn 371, Issue 1-2, 2006, Pages 169-175

  Meshkani, Reza ^a   Taghikhani, Mohammad ^a   Larijani, Bagher ^b   Khatami, Shohreh ^c   Khoshbin, Ehteram ^d   Adeli, Khosrow ^e  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cardiovascular risk factors; Homeostasis model assessment; Insulin resistance; Normal fasting glucose; Normal glucose tolerance

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMOBILIZATION; INSULIN RESISTANCE; IRAN; MALE; MULTIPLE REGRESSION; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FASTING; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IRAN; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OBESITY; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES;

EID: 33746689104     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.03.018     Document Type: Article

References (36)

1. Hanefeld M. The metabolic syndrome: roots, myths, and facts. In: Hanefeld M., and Leonhardt W. (Eds). The metabolic syndrome. Jena, Gustav Fischer (1997) 13-24
2. Reaven G.M. Role of insulin resistance in human disease. Diabetes 37 (1992) 1595-1607
3. Carnevale Schianca G.P., Rossi A., Sainaghi P.P., Maduli E., and Bartoli E. The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care 26 (2003) 1333-1337
4. Boyko E.J., Keane E.M., Marshall J.A., and Hamman R.F. Higher insulin and C-peptide concentrations in Hispanic population at high risk for non-insulin-dependent diabetes mellitus. San Luis Valley Diabetes Study. Diabetes 40 (1991) 509-515
5. Chiu K.C., Cohan P., Lee N.P., and Chuang L.M. Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function. Diabetes Care 23 (2000) 1353-1358
6. Haffner S.M., D'Agostino R., Saad M.F., et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 45 (1996) 742-748
7. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025. Diabetes Care 21 (1998) 1414-1431
8. World Health Organization. Eastern Mediterranean Regional Office, prevention and control of cardiovascular disease, WHO-EMRO, Alexandria, Egypt (1995) 24
9. Zali M., Kazem M., and Masjedi M.R. Health and disease in Iran, Deputy of research (1993), Ministry of health, Tehran Bulletin No. 10 (in Farsi)
10. Onat A., Avc G.S., Senocak M., Ornek E., and Gozukara Y. Plasma lipid and their interaction in Turkish adults. J Epidemiol Community Health 45 (1992) 470-476
11. Expert Committee on the diagnosis and classification of diabetes mellitus: report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
12. Matthews D., Hosker J., Rudenski A., Naylor B., Treacher D., and Turner R. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
13. Bonora E., Kiechl S., Willeit J., et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck study. Diabetes 47 (1998) 1643-16499
14. Ferrannini E., DeFronzo R.A., and Bonadonna R.C. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15 (1992) 318-368
15. Goke B. Implications of blood glucose, insulin resistance and beta-cell function in impaired glucose tolerance. Diabetes Res Clin Pract 40 (1998) S15-S20
16. Mirmiran P., Mohammadi F., Sarbazi N., Allahverdian S., and Azizi F. Gender differences in dietary intakes, anthropometrical measurements and biochemical indices in an urban adult population: the Tehran Lipid and Glucose study. Nutr Metab Cardiovasc Dis 13 (2003) 64-71
17. Lindgarde F., Malmquist J., and Balke B. Physical fitness, insulin secretion, and glucose tolerance in healthy males and mild type 2 diabetes. Acta Diabetol Lac 20 (1983) 33-40
18. Tobey T.A., Greenfield M.S., and Kraemer F. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30 (1981) 165-171
19. McKane W.R., Stevens A.B., and Woods R. The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. Metabolism 39 (1990) 1240-1245
20. Ruige J.B., Assendelft W.J., and Dekker J.M. Insulin and risk of cardiovascular disease. A meta-analysis. Circulation 97 (1998) 996-1001
21. Hanley A.J., Williams K., Stern M.P., and Haffner S.M. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25 (2002) 1177-1184
22. Azizi F., Salehi P., Etemadi A., and Zahedi Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose study. Diabetes Res Clin Res 61 (2003) 29-37
23. Rönnemaa T., Rönnemaa E.M., Puuka P., Pyörälä K., and Laakso M. Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diabetes Care 19 (1996) 1229-1232
24. Tähtinen T.M., Vanhala M.J., Oikarinen J.A., and Keinänen-Kiukaenniemi S.M. Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service. J Cardiovasc Risk 5 (1998) 319-323
25. Nilsson P., Lind L., Pollare T., Berne C., and Lithell H.O. Increased level of hemoglobin A 1c, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers. Metabolism 44 (1995) 557-561
26. Wareham N.J., Ness E.M., Byrne C.D., Cox B.D., Day N.E., and Hales C.N. Cigarette smoking is not associated with hyperinsulinemia: evidence against a causal relationship between smoking and insulin resistance. Metabolism 45 (1996) 1551-1556
27. De Fronzo R.A., Tobin J., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
28. Haffner S.M., Miettinen H., and Stern M.P. The homeostasis model in the San Antonio Heart study. Diabetes Care 20 (1997) 1087-1092
29. Haffner S.M., Kennedy E., and Gonzalez C. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 19 (1996) 1138-1141
30. Taniguchi A., Nakai Y., Sakai M., and Yoshi S. Relationship of regional adiposity to insulin resistance in non obese Japanese type 2 diabetic patients. Diabetes 24 (2001) 966-967
31. Chang S.A., Kim H.S., Yoon K., et al. Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea. Metabolism 53 (2004) 142-146
32. Nabulsi A.A., Folsom A.R., Heiss G., Weir B.S., Chambless L.E., and Watson R.L. Fasting hyperinsulinemia and cardiovascular disease risk factors in non diabetic adults: stronger associations in lean versus obese subjects. Metabolism 44 (1995) 914-922
33. Despres J.P., Lamarche B., Mauriege P., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334 (1996) 952-957
34. Yip J., Facchini F.S., and Reaven G.M. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83 (1998) 2773-2776
35. Austin M.A., Hokanson J.E., and Edwards K.L. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 81 (1998) 7B-12B
36. Ishizakava N., Ishizakava Y., Takahashi E., et al. Association between insulin resistance and carotid arteriosclerosis in subjects with normal fasting glucose and normal glucose tolerance. Arterioscler Thromb Vasc Biol 23 (2003) 295-301